Prognostic value of bone scan index as an imaging biomarker in metastatic prostate cancer: a meta-analysis

Abstract

Baseline BSI and ΔBSI may be beneficial to mPCa prognosis in clinical monitor and treatment. Further high quality studies with larger sample size are required in the future.